A nationwide cohort study in Sweden compared the treatment and survival outcomes of hepatocellular carcinoma (HCC) in cirrhotic versus non-cirrhotic livers. Out of the 4259 identified patients, 34% had HCC in a non-cirrhotic liver. Cirrhotic patients presented at a younger age, had poorer performance status, and a higher prevalence of underlying liver disease. Tumors in non-cirrhotic livers were diagnosed at a more advanced stage and were larger. Cirrhotic patients received curative treatment more frequently and had a superior median survival of 19 months compared to 13 months in non-cirrhotic patients. However, the differences in survival were primarily due to patient and tumor characteristics rather than the cirrhotic status itself.
Journal Article by Engstrand J, Stål P (…) Strömberg C et 2 al. in Scand J Surg
